IP Library Granted Patent US 10,444,233
Granted Patent B2
US 10,444,233 · App. 14/418,406 · Granted Oct 15, 2019

Selective capture and stimulated release of circulating tumor cells on nanostructured devices

Inventors: Hsian-Rong Tseng (Los Angeles, CA); Shuang Hou (Los Angeles, CA); Libo Zhao (Los Angeles, CA); Hsiao-Hua Yu (Saitama, JP); Shyh-Chyang Luo (Saitama, JP); Haichao Zhao (Saitama, JP)
Assignees: The Regents of the University of California; Riken
G01N33/545G01N33/54306G01N33/54346G01N2333/70596
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,444,233
App. No.
14/418,406
Granted
Oct 15, 2019
Kind
B2
Abstract

A device for capturing preselected cell types from a fluid sample that includes a plurality of cell types includes a substrate, a plurality of nanowires at least one of attached to or integral with a surface of the substrate such that each nanowire of the plurality of nanowires has an unattached end, and a layer of temperature-responsive material formed on at least the unattached end of each of the plurality of nanowires. The layer of temperature-responsive material has a compact configuration at a first temperature and an expanded configuration at a second temperature so as to facilitate release of cells captured at the first temperature to be released at the second temperature.

Claims (30)

1. A device for capturing preselected cell types from a fluid sample comprising a plurality of cell types, comprising:

a substrate;

a plurality of nanowires at least one of attached to or integral with a surface of said substrate such that each nanowire of said plurality of nanowires has an unattached end;

a layer of temperature-responsive material formed on at least said unattached end of each of said plurality of nanowires; and

at least one type of cell-selective binding molecule attached to a plurality of portions of said layer of temperature-responsive material,

wherein said layer of temperature-responsive material has a compact configuration at a first temperature and an expanded configuration at a second temperature so as to facilitate release of cells captured at said first temperature to be released at said second temperature,

wherein the first temperature is greater than the second temperature,

wherein said first temperature is greater than 0° C. and less 100′ C, and said second temperature is greater 0° C. and less 100° C.,

wherein said layer of temperature-responsive material formed on at least said unattached end of each of said plurality of nanowires comprises a temperature-responsive polymer,

wherein said temperature-responsive polymer comprises a copolymer comprising a first monomer unit having the formula:

and a second monomer unit that is suitable for attaching a cell-selective binding molecule thereto,

wherein said second monomer unit that is suitable for attaching a cell-selective binding molecule thereto has a formula:

where R 6 is H or

wherein the first monomer unit is in a proportion of about 0.1% to 10% of the second monomer unit, and

wherein a combination of said plurality of nanowires, said layer of temperature-responsive material, and said at least one type of cell-selective binding molecule attached to said plurality of portions of said layer of temperature-responsive material provide a cell capture yield of at least 70% and a cell viability rate following release of at least 20%.

2. The device for capturing preselected cell types according to claim 1 , wherein said first temperature is within a range of temperatures to maintain viability of captured and released cells, and wherein said second temperature is within the range of temperatures to maintain viability of the captured and released cells.

3. The device for capturing preselected cell types according to claim 1 , wherein each of said plurality of nanowires has an average diameter that is less than 500 nanometers.

4. The device for capturing preselected cell types according to claim 1 , wherein each of said plurality of nanowires has an average diameter that is less than 250 nanometers and greater than 20 nanometers.

5. The device for capturing preselected cell types according to claim 1 , wherein each of said plurality of nanowires has an average diameter that is within the inclusive range of 200 nanometers to 100 nanometers.

6. The device for capturing preselected cell types according to claim 1 , wherein said at least one type of cell-selective binding molecule is attached to said layer of temperature-responsive material by at least one of biotin or streptavidin conjugation.

7. The device for capturing preselected cell types according to claim 1 , wherein said cell-selective binding molecule binds to circulating cancer cells (CTCs).

8. The device for capturing preselected cell types according to claim 1 , wherein said cell-selective binding molecule comprises an antibody.

9. The device for capturing preselected cell types according to claim 8 , wherein said antibody comprises at least one of EpCAM, CA19-9, CD146, or CD147 antibodies for the capture of CTCs.

10. The device for capturing preselected cell types according to claim 1 , wherein said cell-selective binding molecule binds to fetal nucleated red blood cells (fNRBCs) from maternal blood.

11. The device for capturing preselected cell types according to claim 8 , wherein said antibody comprises at least one of CD71 or CD147 antibodies for the capture of fetal nucleated red blood cells (fNRBCs) from maternal blood.

12. The device for capturing preselected cell types according to claim 1 , wherein the temperature-responsive polymer is covalently grafted to at least said unattached end of each of said plurality of nanowires.

13. The device for capturing preselected cell types according to claim 1 , wherein said cell-selective binding molecule comprises an antibody.

14. The device for capturing preselected cell types according to claim 13 , wherein said antibody is anti-EpCAM.

15. The device for capturing preselected cell types according to claim claim 1 , wherein said copolymer has a molecular weight in a range of about 4,000 to 20,000 g/mol and a thickness in a range of about 6 nm to 30 nm.

16. The device for capturing preselected cell types according to claim 1 , wherein said first temperature is about 37° C. and said second temperature is about 4° C.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2020
From: RIKEN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 053509/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: YU, HSIAO-HUA; LUO, SHYH-CHYANG; ZHAO, HAICHAO
To: RIKEN
Reel/Frame 035954/0040 →
CONFIRMATORY LICENSE Recorded May 27, 2015
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035782/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: TSENG, HSIAN-RONG; HOU, SHUANG; ZHAO, LIBO
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 035684/0077 →
Continuity (2)
Provisional Application 61677825 · Jul 31, 2012
Related Publication 20150260710A1 · Sep 17, 2015
Cited By (1)
US 12,736,538